day 1 agenda

6th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA
at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event)
Day -1(October 01, 2025)
Tentative Program
09:00-09:30 KeynoteTalk: Genistein (4′,5,7-trihydroxyisoflavone) corrects behavior and improves biochemical parameters in animal models of Alzheimer's disease through autophagy stimulation
Grzegorz Wegrzyn, University of Gdansk, Poland
09:30-10:00 Slot Available
10:00-10:30 KeynoteTalk: Neurogenesis And Plasticity Processes Are Similarly Affected And Damaged In Alzheimer´s Disease
José Julio Rodríguez Arellano, IKERBASQUE, Spain
Group Photo & Refreshment Break (10:30-10:50)
Technical session-I
Themes:
Alzheimer’s Research and Therapy,
Advances in Alzheimer’s and Dementia Research
10:50-11:10 Changes in expression of VGF, SPECC1L, HLA-DRA, and RANBP3L act with APOE E4 to alter risk for late-onset Alzheimer’s disease
Amanda J. Myers, University of Miami, USA
11:10-11:30 Slot Available
11:30-11:50 In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimer's disease 
Paul Chazot, Durham University, UK
11:50-12:10 Biological prognosis toolbox for Alzheimer’s disease and other cognitive neurodegenerative diseases
Marc Teichmann, PITIE SALPETRIERE, France
12:10-12:30 Structural Changes in Cerebral Microvasculature Induced by Ferroptosis Contribute to Blood–Brain Barrier Destruction in Alzheimer's Disease: An Autopsy Study
Yuan Cao, Peking Union Medical College Hospital, China
12:30-12:50 Three scenarios for amyloid transformation 
Irena K. Roterman, Jagiellonian University – Medical College , Poland
12:50-13:10  Advancing dementia screening, care, and research in Kenya: challenges
and opportunities
DAVID NDETEI, University of Nairobi / Africa Institute of Mental and Brain Health, Kenya
Lunch Break @ Restaurant (13:10-14:00)
Technical session-II
Themes:
Dementia care research and Practice,
Dementia diagnosis, treatment & Amyloid and Tau Protein
14:00-14:20 Cerebral Capillopathy Nexus of Neurodegenerative disease
Charles R Joseph, Liberty University College of Osteopathic Medicine, USA
14:20-14:40 Older adults with dementia:knowledge and attitudes of physicians in health units
ANA BEATRIZ QUINTES STEINER, UNIFESP, Brazil
14:40-15:00 Slot Available
15:00-15:20  Short and Long-term Effects of Transcranial Alternating Electrical Stimulation Paired with Cognitive Exercises as a Treatment for Cognitive Impairment
Zahra Moussavi, University of Manitoba, Canada
15:20-15:40 Dihydromyricetin as a Dual-Target Neuroprotector: Clearing Tau and Aβ for Alzheimer's Disease Intervention
Judy Qiao, Towncom International Group, USA
15:40:16:00  Extracellular Tau and S100A9 proteins induce phagoptosis of live neurons
Vilma Borutaite, Lithuanian University of Health Sciences, Lithunia
16:20:16:40 Slot Available
Refreshment Break(16:40-17:00)
Note: This is a Tentative program, subjects and timings will changes.
Abstract submissions are open now. To schedule your talk in the program please email to: [email protected]
Day-1 Concludes

day 2 agenda

Day -2(October 02, 2025)
Tentative Program
09:00-09:30 Keynote Talk: Exploring Immune Dysregulation and Gut-Nutrient Disruption in Alzheimer’s Disease Pathology
Catherine C L Wong, Peking Union Medical College Hospital, China
09:30-10:00 Slot Available
10:00-10:30 Slot Available
Group Photo & Refreshment Break (10:30-10:50)
Technical session-III
Themes:
Neurodegenerative Diseases,Risk reduction and prevention &
Clinical Trials and Therapeutics
10:50-11:10 Heparan sulfate modified protein signaling and neurodegenerative disease
Scott Selleck, Pennsylvania State University, USA
11:10-11:30 Maternal and early life exposure induced AD- like pathophysiology
Aluru Parithathvi, Manipal School of Life Sciences, India
11:30-11:50 Semaglutide ameliorates Alzheimer’s disease and restores oxytocin in APP/ PS1 mice and human brain organoid models
Zhihui Zhong, Sichuan University West China Hospital, China
11:50-12:10 Hearing Loss &Tinnitus – Reducing the Risk of Cognitive Decline
Keith N. Darrow, Worcester State University, USA
12:10-12:30 Slot Available
12:30-12:50 One-week inpatient cognitive behavioral therapy for insomnia: a retrospective study
Qifang Li, Tongji university, China
12:50-13:10 A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
Alison Buchholz, The Johns Hopkins University School of Medicine, USA
13:10-13:30  The efficacy of Sham rTMS stimulation
Brian Lithgow, University of Manitoba, Canada
Lunch Break @ Restaurant (13:30-14:30)
Poster Presentations
PP-1 In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease 
Yunxi Zhang, Durham University, UK
PP-2 Probing Monoclonal Antibody Specificity for Designing Alzheimer's Vaccines
Anne-Cathrine Vogt, University of Bern, Switzerland
PP-3 Slot Available
PP-4 Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study
Norah Alanazi, Durham University, UK
PP-5 FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice
Christakis Damianou, Cyprus University of Technology, Cyprus
PP-6 Slot Available
Abstract submissions are open now. To schedule your talk in the program please email to: [email protected]
Day-2 Concludes

posters agenda

Poster Presentations
PP-1 In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease 
Yunxi Zhang, Durham University, UK
PP-2 FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice
Christakis Damianou, Cyprus University of Technology, Cyprus
PP-3 Slot Available
PP-4 Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study
Norah Alanazi, Durham University, UK
PP-5 Probing Monoclonal Antibody Specificity for Designing Alzheimer's Vaccines
Anne-Cathrine Vogt, University of Bern, Switzerland
PP-6 Slot Available
Abstract submissions are open now. To schedule your talk in the program please email to: [email protected]

posters agenda

6th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA
at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event)
Tentative Program
Day -1(October 01, 2025)
Virtual Program
09:00-09:20 CareWindow: Enhancing Communication for Seniors and Individuals with Disabilities
Zachary Bailey, Care Window, Australia
09:20-09:40 Slot Available
09:40-10:10 Keynote Talk: Sex-specific brain protection in the clinical scenario: the case of davuentide
Illana Gozes, Tel Aviv University, Israel
10:10-10:30 Understanding Depression Through Metaphors: Insights into Cognitive and Behavioral Patterns in Online Health Communities
Jiayi Shi, Xi'an Jiaotong University, China
10:30-10:50 Slot Available
10:50-11:10 From Phenotype Drug Screening to Biological Target identification for
Alzheimer’s disease-modifying development
SERGEANT Nicolas, University of Lille, France
11:10-11:30  Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial
Dean Ornish,  Preventive Medicine Research Institute, USA
11:30-11:50 Slot Available
11:50-12:10 Successes and Challenges: Insights from the first six months of the CONNECT program
Chitrali R. Mamlekar & Melissa A. Alunni, Misericordia University, USA
12:10-12:30 Slot Available
12:30-12:50 Clinicians' Reluctance to Implement a Deeply Demented Patient's Advance Directive: A Broken Moral Compass  
Norman L. Cantor, Retired from Rutgers University, USA
12:50-13:10 Slot Available
13:10-13:30 P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little?
Caroline Jose, Vitalité Health Network, Canada
13:30-13:50 Slot Available
13:50-14:10 An integrative review about electrophysiological biomarkers of cognitive impairment in Alzheimer’s disease: A developing relationship
Ezra C. Holston, University of Nevada Reno, USA
14:10-14:30 Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Clifford R. Jack, Mayo Clinic, USA
14:30-14:50 Slot Available
14:50-15:10 Aging as a target for the prevention and treatment of Alzheimer’s disease
Raymond Scott Turner, Georgetown University, USA
15:10-15:30 Futuristic Alzheimer's therapy: acoustic-stimulated piezoelectric nanospheres for amyloid reduction
Manju Sharma, University of Georgia, USA
15:30-15:50 Slot Available
Day-1 Concludes
   
Day -2(October 02, 2025)
Virtual Program
09:00-09:20 A perspective on physical therapy approaches in motor function neurorehabilitation
Fengxue Qi, Beijing Sport University, China
09:20-09:40 Slot Available
09:40-10:00 Students’ core self-evaluation, psychological capital, and academic engagement: A case study of Romania and Serbia
Elena Mirela Samfira, University of Life Sciences „King Mihai I” from Timisoara, Romania
10:00-10:20 The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
Xinling Wang, Freiburg University Medical Center, Germany
10:20-10:40 Exploring the Developmental Regulation Network of Human Serotonin Neurons via Florescent Reporter Systems
Jianfeng LU, Tongji University, China
10:40-11:00 Slot Available
11:00-11:20 OXYGEN-OZONE THERAPY AND COGNITIVE FRAILTY: A NONPHARMACOLOGICAL APPROACH TO POTENTIALLY RESOLVE IMMUNE AND INFLAMMATORY DYSFUNCTIONS
Antonio Carlo Galoforo, University of Pavia, Italy
11:20-11:40 Slot Available
11:40-12:00 Understanding Systems and Cognitive Process to Lead Change with Compassion
Elizabeth Wilhelm-Alderton & Renae Swanson, University of Wisconsin - Oshkosh, USA
12:00-12:20 Proposed Micronutrient Mixture, Probiotics, Collagen Peptides, Omega3, and  Cannabidiol (CBD) may Reduce Aging, and  Development and Progression of Alzheimer’s disease, and Improve its Treatment
Kedar N Prasad, Engage Global, Inc, USA
12:20-12:40 Severe COVID-19 is associated with transcriptomic signatures of aging in the human brain
Maria Mavrikaki, Harvard Medical School, USA
12:40-13:00 Slot Available
13:00-13:20 Psychosocial factors associated with the risk of developing psychosis in Mexico
Tecelli Domínguez Martínez, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico
13:20-13:40 Amyloid β fragments that suppress oligomers but not fibrils are cytoprotective 
Suren A. Tatulian, University of Central Florida, USA
13:40-14:00 Passive exposure to novel stimuli drives neural adaptation that encodes stimulus statistics in songbird auditory forebrain
David S. Vicario, Rutgers University, USA
14:00-14:20 Slot Available
14:20-14:40 Blood-brain barrier permeability contributes to cognitive impairment in the aftermath of SARS-CoV-2 infection: a role for cerebrovascular Wnt/beta-Catenin and Caveolin-1
Sarah E. Lutz, University of Illinois at Chicago, USA
14:40-15:00 Curcumin and omega-3 fatty acids: nutraceuticals against Alzheimer's disease
Luz Velasco, Universidad Veracruzana, Mexico
15:00-15:20 Slot Available
15:20-15:40 NeoRhythm: A Neurocardiac Electrophysiology Based Explainable EEG and ECG System for Detection of Neonatal Seizures
Roshan Amurthur, Harker University, USA
15:40-16:00 How Children Learn To Understand Language Meanings
Stephen Grossberg, Boston University, USA
Abstract submissions are open now. To schedule your talk in the program, please email to: [email protected]

Download